Comparison

BC-1215

Item no. CAPS-C07126-5mg
Manufacturer Capsid Biotechnology
CASRN 1507370-20-8
Amount 5 mg
Quantity options 25 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles C1=CC=NC(=C1)C2=CC=C(C=C2)CNCCNCC3=CC=C(C=C3)C4=CC=CC=N4
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Storage Conditions
3 years -20°C powder
Small Target
E3 Ligase
Big Target
Ubiquitin
Information
BC-1215 is an inhibitor of F-box protein 3 (Fbxo3, a ubiquitin E3 ligase component) with IC50 of 0.9 μg/mL and LC50 of 87 μg/ml for IL-1β release. BC-1215 inhibits the Fbxo3-TRAF activation pathway by destabilizing TRAF1-6.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close